Amgen to terminate participation in co-development and commercialization of brodalumab

Go back to Amgen to terminate participation in co-development and commercialization of brodalumab
Amgen Inc (NASDAQ: AMGN) Delayed: 366.29 -5.29 (1.42%)
Previous Close $371.58    52 Week High $176.85 
Open $373.97    52 Week Low $133.64 
Day High $378.54    P/E 55.16 
Day Low $361.72    EPS $6.64 
Volume 2,861,316       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 1,981,332       

Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) Delayed: 17.91 +0.19 (1.07%)
Previous Close $17.72    52 Week High $18.64 
Open $18.00    52 Week Low $12.59 
Day High $18.00    P/E N/A 
Day Low $17.89    EPS $0.00 
Volume 14,410